Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23091)

• Formulation Name: Bretylium 50mg/ml injectable
• Company: Ani Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Bretylium	(DM1FX74)	Ventricular fibrillation	BC71.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Hydrochloric acid	(E00015)	313	Acidulant
Sodium hydroxide	(E00234)	14798	Alkalizing agent